Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012480 |
---|---|
Receipt number | R000014596 |
Scientific Title | A phase 2 study of combination neoadjuvant chemotherapy with gemcitabine S-1 and leucovorin in patients with borderline and locally advanced pancreatic cancer |
Date of disclosure of the study information | 2013/12/04 |
Last modified on | 2019/06/09 14:43:39 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/12/03 23:03:25 | ||
2 | Update | 2017/05/31 18:29:02 | Recruitment status |
|
3 | Update | 2017/12/06 22:35:21 | Last name of lead principal investigator Last name of lead principal investigator Name of primary person or sponsor Organization Organization Organization |
|
4 | Update | 2019/06/09 14:20:41 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
5 | Update | 2019/06/09 14:22:07 | Number of participants that the trial has enrolled |
|
6 | Update | 2019/06/09 14:23:27 | Recruitment status Date of IRB Last follow-up date |
|
7 | Update | 2019/06/09 14:43:39 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |